Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.5.4, replacing the previous v3.5.3, indicating a new version of the study documentation.
    Difference
    0.1%
    Check dated 2026-05-15T23:54:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than a change to the trial’s published content.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:45.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:11.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed, indicating a site version update.
    Difference
    0.1%
    Check dated 2026-03-19T20:57:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:46.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 instead of v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:50.000Z thumbnail image

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.